| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 32.783 | 51.507 | 55.788 | 65.897 | 70.541 | 92.226 | 93.118 | 119.395 | 135.384 |
| Total Income - EUR | - | 32.803 | 51.507 | 55.788 | 65.940 | 72.671 | 92.310 | 93.194 | 119.395 | 137.059 |
| Total Expenses - EUR | - | 19.587 | 40.703 | 48.712 | 60.248 | 67.381 | 59.800 | 73.586 | 87.850 | 116.627 |
| Gross Profit/Loss - EUR | - | 13.216 | 10.804 | 7.077 | 5.691 | 5.290 | 32.510 | 19.607 | 31.545 | 20.432 |
| Net Profit/Loss - EUR | - | 12.888 | 10.289 | 6.519 | 5.032 | 4.619 | 31.605 | 18.694 | 30.375 | 16.402 |
| Employees | - | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
Check the financial reports for the company - M&S Hipomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 135 | 0 | 0 | 675 | 481 | 294 | 1.184 | 10.034 | 8.454 |
| Current Assets | - | 15.350 | 13.147 | 15.617 | 16.457 | 16.978 | 35.650 | 22.508 | 37.443 | 23.515 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 3.688 | 3.826 | 4.043 | 5.067 | 5.303 | 6.801 | 14.038 | 17.069 | 382 |
| Cash | - | 11.662 | 9.322 | 11.574 | 11.390 | 11.675 | 28.848 | 8.469 | 20.374 | 23.132 |
| Shareholders Funds | - | 12.932 | 10.341 | 12.157 | 12.107 | 11.121 | 31.654 | 18.742 | 30.424 | 16.451 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.553 | 2.806 | 3.460 | 5.025 | 6.338 | 4.290 | 4.949 | 17.053 | 15.519 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - M&S Hipomed Srl